![Christopher Martell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 5 M $ in data 31/05/2026
Christopher Martell is currently an Independent Director at Candel Therapeutics, Inc. since 2018 and a Manager at Gtam1 2012 Adv LLC.
Former roles include Managing Director-Healthcare Investment Banking at J.P.
Morgan & Co., Inc. (Delaware) and Partner at PBM Capital Group LLC.
Education includes an undergraduate degree from Yale University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 23/06/2026 | 546.863 ( 0,75% ) | 5 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/11/2018 |
| Società | Posizione | Fine |
|---|---|---|
J.P. Morgan & Co., Inc. (Delaware)
 J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PBM Capital Group LLC
PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements. | Finance |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
J.P. Morgan & Co., Inc. (Delaware)
J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
